BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 33052720)

  • 1. LI-RADS: Past, Present, and Future, From the
    Marks RM; Masch WR; Chernyak V
    AJR Am J Roentgenol; 2021 Feb; 216(2):295-304. PubMed ID: 33052720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI.
    Elsayes KM; Kielar AZ; Elmohr MM; Chernyak V; Masch WR; Furlan A; Marks RM; Cruite I; Fowler KJ; Tang A; Bashir MR; Hecht EM; Kamaya A; Jambhekar K; Kamath A; Arora S; Bijan B; Ash R; Kassam Z; Chaudhry H; McGahan JP; Yacoub JH; McInnes M; Fung AW; Shanbhogue K; Lee J; Deshmukh S; Horvat N; Mitchell DG; Do RKG; Surabhi VR; Szklaruk J; Sirlin CB
    Abdom Radiol (NY); 2018 Oct; 43(10):2625-2642. PubMed ID: 30155697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
    Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
    Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality Imaging of Hepatocellular Carcinoma: From Diagnosis to Treatment Response Assessment in Everyday Clinical Practice.
    Delli Pizzi A; Mastrodicasa D; Cianci R; Serafini FL; Mincuzzi E; Di Fabio F; Giammarino A; Mannetta G; Basilico R; Caulo M
    Can Assoc Radiol J; 2021 Nov; 72(4):714-727. PubMed ID: 32436394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic efficacy of contrast-enhanced ultrasound versus MRI Liver Imaging Reporting and Data System (LI-RADS) for categorising hepatic observations in patients at risk of hepatocellular carcinoma.
    Li S; Zhou L; Chen R; Chen Y; Niu Z; Qian L; Fang Y; Xu L; Xu H; Zhang L
    Clin Radiol; 2021 Feb; 76(2):161.e1-161.e10. PubMed ID: 33198943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 9. Introduction to the Liver Imaging Reporting and Data System for Hepatocellular Carcinoma.
    Tang A; Singal AG; Mitchell DG; Hecht EM; Fowler KJ; Kulik L; Parikh ND; Kono Y; Sirlin CB
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1228-1238. PubMed ID: 30326302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT/MR LI-RADS 2018: clinical implications and management recommendations.
    Kamath A; Roudenko A; Hecht E; Sirlin C; Chernyak V; Fowler K; Mitchell DG
    Abdom Radiol (NY); 2019 Apr; 44(4):1306-1322. PubMed ID: 30671612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Imaging Reporting and Data System (LI-RADS) v2018: Review of the CT/MRI Diagnostic Categories.
    Kanmaniraja D; Dellacerra G; Holder J; Erlichman D; Chernyak V
    Can Assoc Radiol J; 2021 Feb; 72(1):142-149. PubMed ID: 32063008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
    Schellhaas B; Hammon M; Strobel D; Pfeifer L; Kielisch C; Goertz RS; Cavallaro A; Janka R; Neurath MF; Uder M; Seuss H
    Eur Radiol; 2018 Oct; 28(10):4254-4264. PubMed ID: 29675659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance.
    Elsayes KM; Kielar AZ; Chernyak V; Morshid A; Furlan A; Masch WR; Marks RM; Kamaya A; Do RKG; Kono Y; Fowler KJ; Tang A; Bashir MR; Hecht EM; Jambhekar K; Lyshchik A; Rodgers SK; Heiken JP; Kohli M; Fetzer DT; Wilson SR; Kassam Z; Mendiratta-Lala M; Singal AG; Lim CS; Cruite I; Lee J; Ash R; Mitchell DG; McInnes MDF; Sirlin CB
    J Hepatocell Carcinoma; 2019; 6():49-69. PubMed ID: 30788336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.
    Ding J; Long L; Zhang X; Chen C; Zhou H; Zhou Y; Wang Y; Jing X; Ye Z; Wang F
    Eur Radiol; 2021 Feb; 31(2):847-854. PubMed ID: 32803416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI.
    Wilson SR; Lyshchik A; Piscaglia F; Cosgrove D; Jang HJ; Sirlin C; Dietrich CF; Kim TK; Willmann JK; Kono Y
    Abdom Radiol (NY); 2018 Jan; 43(1):127-142. PubMed ID: 28819825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of LI-RADS Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma in Liver Transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI.
    Bae JS; Lee JM; Yoon JH; Kang HJ; Jeon SK; Joo I; Lee KB; Kim H
    Radiology; 2021 May; 299(2):336-345. PubMed ID: 33650901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system.
    Kim TK; Noh SY; Wilson SR; Kono Y; Piscaglia F; Jang HJ; Lyshchik A; Dietrich CF; Willmann JK; Vezeridis A; Sirlin CB
    Clin Mol Hepatol; 2017 Dec; 23(4):280-289. PubMed ID: 28911220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. User and system pitfalls in liver imaging with LI-RADS.
    Elsayes KM; Fowler KJ; Chernyak V; Elmohr MM; Kielar AZ; Hecht E; Bashir MR; Furlan A; Sirlin CB
    J Magn Reson Imaging; 2019 Dec; 50(6):1673-1686. PubMed ID: 31215119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the Liver Imaging Reporting and Data System: What the Pathologist Needs to Know.
    Tang A; Valasek MA; Sirlin CB
    Adv Anat Pathol; 2015 Sep; 22(5):314-22. PubMed ID: 26262514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contrast-enhanced ultrasound: Liver Imaging Reporting and Data System (CEUS LI-RADS)].
    Dietrich CF; Potthoff A; Helmberger T; Ignee A; Willmann JK;
    Z Gastroenterol; 2018 May; 56(5):499-506. PubMed ID: 29734449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.